Studies on Chemotherapeutics. XXXII

The COPD Pipeline XXXII.

COPD accounts for approximately 26 million prescriptions per year in the United States. According to an analysis by Novartis R&D, the U.S. market for COPD drugs was running at $11.8 billion in 2012, 70% of that fi gure being almost equally divided between a LAMA, namely tiotropium, and the 2 ICS/LABA combinations. Th eir estimate is that the COPD drug market will increase by 24.4% to $14.8 bill...

Antifungal chemotherapeutics.

This review addresses trends in outcome and risk factors for invasive fungal infections, current antifungal agents and new therapeutic strategies. Current prospects for new therapies rest upon caspofungin, the first of a new class of antifungal molecules, the echinocandins, and new extended-spectrum azoles, voriconazole, posaconazole and ravuconazole. Approval by the Food and Drug Administratio...

of Economic Literature , Vol . XXXII ( December 1994 )

Xxxii. the Heat-stable Peroxidase of Bacteria

Xxxii Malignant Mesothelioma of the Pleura

nodule of tumor tissue which grossly compressed the adjacent normal appearing liver substance. Gros8 Pathological Diagnoses: 1. Bronchogenic carcinoma, right upper lobe bronchus with metastases to both lungs, hilar lymph nodes, and nodule in the liver. 2. Generalized arteriosclerosis. 3. Arteriolar sclerosis, kidneys. 4. Nodular hyperplasia, prostate. 5. Cholelithiasis. With hematoxylin and eos...